Articles

Stay ahead of the game with critical insights, market explorations, and new perspectives. Unbiased and independent. Now that’s refreshing!

Home  >  articles  >  healthcare medical

Healthcare & Medical Articles

Latest
Investor Education
Shares
Macro
Asset Allocation
Investment Themes
Fixed Interest
Property
ETF
ESG
Commodities
Managed Fund
Private Assets
Technology
Alternative Investment
FEATURED
Healthcare & Medical · Investment Themes · 5 MIN READ

Prepare for a resurgence of the healthcare sector

2024 was a bumpy ride for global healthcare investors with the sector lagging most economically sensitive sectors. There were also sector-specific challenges to navigate in the form of margin pressure, workforce shortages, and digital disruption. But at this juncture, the global healthcare sector’s fundamentals are stronger than ever thanks to a step-change in recent innovation as well as favourable demographic changes. Investors should arguably position themselves for a sector recovery…

Simon Turner - Head of Content (CFA)
Simon TurnerHead of Content (CFA)
29 Jan 2025

Is the medtech sector set to party like it’s 1995?

Better treating chronic disease has long been a core objective for the global medtech sector. Whilst steady progress in that direction has the name of the game for decades, the medtech sector appears to be at an inflection point with a secular improvement in treatment standards occurring in recent years. Less-young investors (I’m being polite) will remember a similar feeling in the global technology sector back in 1995, during the early stages of the tech boom.

Investment ThemesHealthcare & MedicalManaged Fund
1 Mar 2024
 · Simon Turner
 · 7 MIN READ

Beyond the Ozempic hype

There has been considerable hype lately surrounding the weight-loss drugs Ozempic/Wegovy which was initially designed for managing diabetes. From short sellers who believe Ozempic will disrupt competitors to endorsements by high-profile figures like Elon Musk and former UK Prime Minister Boris Johnson, these slimming drugs have transcended medical circles, shaking up entire industries from biotech and healthcare to fast food.

Investment ThemesSharesHealthcare & Medical
21 Nov 2023
 · Ankita Rai
 · 5 MIN READ

Is the medtech sector set to party like it’s 1995?

Better treating chronic disease has long been a core objective for the global medtech sector. Whilst steady progress in that direction has the name of the game for decades, the medtech sector appears to be at an inflection point with a secular improvement in treatment standards occurring in recent years. Less-young investors (I’m being polite) will remember a similar feeling in the global technology sector back in 1995, during the early stages of the tech boom.

Investment ThemesHealthcare & MedicalManaged Fund
1 Mar 2024
 · Simon Turner
 · 7 MIN READ

Beyond the Ozempic hype

There has been considerable hype lately surrounding the weight-loss drugs Ozempic/Wegovy which was initially designed for managing diabetes. From short sellers who believe Ozempic will disrupt competitors to endorsements by high-profile figures like Elon Musk and former UK Prime Minister Boris Johnson, these slimming drugs have transcended medical circles, shaking up entire industries from biotech and healthcare to fast food.

Investment ThemesSharesHealthcare & Medical
21 Nov 2023
 · Ankita Rai
 · 5 MIN READ

Explore 100's of investment opportunities and find your next hidden gem!

Search and compare a purposely broad range of investments and connect directly with product issuers.

Explore Investments
0